The proliferation of thyroid cancer cells induced by ALK fusions in vitro and in nude mice was blocked by crizotinib and TAE684 (ALK inhibitors), which indicated ALK fusions as a potential therapeutic target of thyroid carcinomas (32). The gene discussed is ALK; the disease is thyroid cancer.